Barinthus Biotherapeutics plc annual operating margin
2020
2021
2022
2023
2024
Barinthus Biotherapeutics plc's operating margin was −454.07% for fiscal 2024.
View full Barinthus Biotherapeutics plc company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −454.07% | +10009.02 pp |
| 2023 | 2023-12-31 | −10,463.09% | −10454.05 pp |
| 2022 | 2022-12-31 | −9.04% | +16864.47 pp |
| 2021 | 2021-12-31 | −16,873.51% | −16457.70 pp |
| 2020 | 2020-12-31 | −415.81% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2024 | 2024-09-30 | −62.66% | −180.04 pp |
| Q2 2023 | 2023-06-30 | −7,885.33% | −7962.89 pp |
| Q1 2023 | 2023-03-31 | −4,590.60% | −4594.95 pp |
| Q4 2022 | 2022-12-31 | −389.75% | +28747.09 pp |
| Q3 2022 | 2022-09-30 | 117.37% | +48245.94 pp |
| Q2 2022 | 2022-06-30 | 77.57% | +2948.26 pp |
| Q1 2022 | 2022-03-31 | 4.35% | +2725.54 pp |
| Q3 2021 | 2021-09-30 | −29,136.84% | −29092.92 pp |
| Q2 2021 | 2021-06-30 | −48,128.57% | −47280.04 pp |
| Q1 2021 | 2021-03-31 | −2,870.70% | −2211.27 pp |
| Q4 2020 | 2020-12-31 | −2,721.19% | — |
| Q3 2020 | 2020-09-30 | −43.92% | — |
| Q2 2020 | 2020-06-30 | −848.53% | — |
| Q1 2020 | 2020-03-31 | −659.43% | — |
Across the available reported history, Barinthus Biotherapeutics plc's operating margin increased from −10,463.09% to −454.07%, a change of +10009.02 percentage points. The latest reported quarter, Q3 2024, shows −62.66%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Barinthus Biotherapeutics plc filings at SEC.gov ↗